Log in
NASDAQ:XERS

Xeris Pharmaceuticals News Headlines

$4.92
+0.03 (+0.61 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.69
Now: $4.92
$5.02
50-Day Range
$4.81
MA: $5.58
$6.59
52-Week Range
$1.42
Now: $4.92
$9.69
Volume1.31 million shs
Average Volume1.89 million shs
Market Capitalization$227.71 million
P/E RatioN/A
Dividend YieldN/A
Beta2.22

Headlines

Xeris Pharmaceuticals (NASDAQ XERS) News Headlines Today

Source:
SourceHeadline
Xeris Pharmaceuticals (NASDAQ:XERS) Stock Rating Lowered by BidaskClubXeris Pharmaceuticals (NASDAQ:XERS) Stock Rating Lowered by BidaskClub
marketbeat.com - September 25 at 6:10 AM
Xeris Pharmaceuticals (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseXeris Pharmaceuticals (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:05 PM
Is Xeris Pharmaceuticals (NASDAQ:XERS) Weighed On By Its Debt Load?Is Xeris Pharmaceuticals (NASDAQ:XERS) Weighed On By Its Debt Load?
finance.yahoo.com - October 28 at 5:20 PM
Xeris Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XERS)Xeris Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XERS)
americanbankingnews.com - October 21 at 1:53 PM
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For InjectionXeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
finance.yahoo.com - October 20 at 7:07 PM
Xeris Pharmaceuticals (NASDAQ:XERS) Trading Up 8.7%Xeris Pharmaceuticals (NASDAQ:XERS) Trading Up 8.7%
americanbankingnews.com - October 19 at 7:04 PM
Shark Bites: Convergence of News and Technicals Makes Xeris InterestingShark Bites: Convergence of News and Technicals Makes Xeris Interesting
finance.yahoo.com - October 19 at 6:43 PM
Xeris Pharmaceuticals (NASDAQ:XERS)  Shares Down 5.3% Xeris Pharmaceuticals (NASDAQ:XERS) Shares Down 5.3%
americanbankingnews.com - October 9 at 8:01 PM
Xeris Pharmaceuticals (NASDAQ:XERS) Trading 5.5% Higher Xeris Pharmaceuticals (NASDAQ:XERS) Trading 5.5% Higher
americanbankingnews.com - October 8 at 8:04 PM
Xeris Pharmaceuticals'(NASDAQ:XERS) Share Price Is Down 31% Over The Past Year.Xeris Pharmaceuticals'(NASDAQ:XERS) Share Price Is Down 31% Over The Past Year.
finance.yahoo.com - September 22 at 4:39 PM
Thinking about buying stock in Marinus Pharmaceuticals, Fiat Chrysler, Lithium Americas, Xeris Pharmaceuticals, or Nokia?Thinking about buying stock in Marinus Pharmaceuticals, Fiat Chrysler, Lithium Americas, Xeris Pharmaceuticals, or Nokia?
marketwatch.com - September 15 at 10:08 AM
Xeris Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceXeris Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 9:52 AM
Xeris Looks Like A High-Quality Platform Play As Gvoke Sales IncreaseXeris Looks Like A High-Quality Platform Play As Gvoke Sales Increase
seekingalpha.com - August 31 at 1:14 AM
XERS Aug 2020 2.500 callXERS Aug 2020 2.500 call
au.finance.yahoo.com - August 23 at 8:57 AM
Xeris Pharmaceuticals Appoints John Shannon President and Chief Operating OfficerXeris Pharmaceuticals Appoints John Shannon President and Chief Operating Officer
finance.yahoo.com - August 20 at 8:20 PM
FDA warns Xeris over Gvoke ad; shares down 13%FDA warns Xeris over Gvoke ad; shares down 13%
seekingalpha.com - August 20 at 3:15 PM
Are Options Traders Betting on a Big Move in Xeris Pharmaceuticals (XERS) Stock?Are Options Traders Betting on a Big Move in Xeris Pharmaceuticals (XERS) Stock?
finance.yahoo.com - August 18 at 2:12 PM
Xeris Pharmaceuticals (XERS) Looks Good: Stock Adds 5.1% in SessionXeris Pharmaceuticals (XERS) Looks Good: Stock Adds 5.1% in Session
finance.yahoo.com - August 11 at 11:29 AM
Xeris Pharmaceuticals, Inc. (XERS) CEO Paul Edick on Q2 2020 Results - Earnings Call TranscriptXeris Pharmaceuticals, Inc. (XERS) CEO Paul Edick on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 5:23 PM
Xeris Pharmaceuticals, Inc. (XERS) Q2 2020 Earnings Call TranscriptXeris Pharmaceuticals, Inc. (XERS) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 10 at 5:23 PM
Recap: Xeris Pharmaceuticals Q2 EarningsRecap: Xeris Pharmaceuticals Q2 Earnings
finance.yahoo.com - August 10 at 12:23 PM
Xeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Lags Revenue EstimatesXeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 12:23 PM
Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate HighlightsXeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights
finance.yahoo.com - August 10 at 7:19 AM
Xeris Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020Xeris Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020
finance.yahoo.com - August 3 at 7:00 PM
Xeris Pharmaceuticals Announces Additional Data From a Phase 1b Comparative Study of Its Novel Concentrated Diazepam Formulation (XP-0863) and an Expedited Clinical Path ForwardXeris Pharmaceuticals Announces Additional Data From a Phase 1b Comparative Study of Its Novel Concentrated Diazepam Formulation (XP-0863) and an Expedited Clinical Path Forward
finance.yahoo.com - July 30 at 9:48 AM
Xeris Pharmaceuticals Announces Full Exercise of Underwriters’ Options to Purchase Additional Shares and Additional NotesXeris Pharmaceuticals Announces Full Exercise of Underwriters’ Options to Purchase Additional Shares and Additional Notes
finance.yahoo.com - July 15 at 8:38 PM
Xeris Spikes 12% After-Hours On Soros Stake; Analyst Says BuyXeris Spikes 12% After-Hours On Soros Stake; Analyst Says Buy
finance.yahoo.com - July 12 at 8:19 AM
Xeris Pharma up 11% after hours on Soros stakeXeris Pharma up 11% after hours on Soros stake
seekingalpha.com - July 10 at 6:59 PM
Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)
finance.yahoo.com - July 6 at 12:53 PM
Xeris Pharma launches Gvoke HypoPen for hypoglycemia in U.S.Xeris Pharma launches Gvoke HypoPen for hypoglycemia in U.S.
seekingalpha.com - July 1 at 9:38 AM
2 Beaten-Up Penny Stocks That Look Set for a Rebound2 Beaten-Up Penny Stocks That Look Set for a Rebound
finance.yahoo.com - June 30 at 6:23 PM
Xeris Pharmaceuticals (XERS) in Focus: Stock Moves 6.8% HigherXeris Pharmaceuticals (XERS) in Focus: Stock Moves 6.8% Higher
finance.yahoo.com - June 30 at 1:23 PM
Xeris Pharma prices stock and convertible debt offeringsXeris Pharma prices stock and convertible debt offerings
seekingalpha.com - June 26 at 9:30 AM
Xeris Pharmaceuticals Announces Proposed Public Offerings of $20 Million of Common Stock and $60 Million of Convertible Senior NotesXeris Pharmaceuticals Announces Proposed Public Offerings of $20 Million of Common Stock and $60 Million of Convertible Senior Notes
finance.yahoo.com - June 24 at 5:36 PM
Xeris Pharma pramlintide-insulin candidate shows benefit in mid-stage studyXeris Pharma pramlintide-insulin candidate shows benefit in mid-stage study
seekingalpha.com - June 18 at 1:01 PM
Xeris Pharmaceuticals Announces Positive Topline Results from the Phase 2 Comparative Study of a Novel Pramlintide-insulin Co-formulation (XP-3924) in Adults with Type 1 Diabetes MellitusXeris Pharmaceuticals Announces Positive Topline Results from the Phase 2 Comparative Study of a Novel Pramlintide-insulin Co-formulation (XP-3924) in Adults with Type 1 Diabetes Mellitus
finance.yahoo.com - June 18 at 1:01 PM
Faruqi & Faruqi, LLP is Investigating Xeris Pharmaceuticals, Inc. (XERS) on Behalf of its ShareholdersFaruqi & Faruqi, LLP is Investigating Xeris Pharmaceuticals, Inc. (XERS) on Behalf of its Shareholders
finance.yahoo.com - June 15 at 12:28 PM
Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk ...Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk ...
www.businesswire.com - June 15 at 7:27 AM
Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk of Hypoglycemia During and After Aerobic ExerciseXeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk of Hypoglycemia During and After Aerobic Exercise
finance.yahoo.com - June 15 at 7:27 AM
Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients ...Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients ...
www.businesswire.com - May 22 at 12:47 PM
Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients at Risk of Postprandial Hypoglycemia Following Bariatric SurgeryXeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients at Risk of Postprandial Hypoglycemia Following Bariatric Surgery
finance.yahoo.com - May 22 at 12:47 PM
The President of Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), Paul Edick, Just Bought 32% More SharesThe President of Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), Paul Edick, Just Bought 32% More Shares
finance.yahoo.com - May 15 at 1:15 AM
Xeris Pharma inks distribution deal for Gvoke outside U.S.Xeris Pharma inks distribution deal for Gvoke outside U.S.
seekingalpha.com - May 14 at 10:12 AM
Xeris Pharmaceuticals, Inc. (XERS) Q1 2020 Earnings Call TranscriptXeris Pharmaceuticals, Inc. (XERS) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 5:29 PM
Xeris Pharmaceuticals (XERS) CEO Paul Edick on Q1 2020 Results - Earnings Call TranscriptXeris Pharmaceuticals' (XERS) CEO Paul Edick on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 1:34 AM
NetworkNewsBreaks - Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) to Announce Q1 2020 Financial Results, Host Conference CallNetworkNewsBreaks - Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) to Announce Q1 2020 Financial Results, Host Conference Call
www.marketwatch.com - May 7 at 5:10 PM
Xeris Pharmaceuticals EPS misses by $0.05, beats on revenueXeris Pharmaceuticals EPS misses by $0.05, beats on revenue
seekingalpha.com - May 7 at 12:09 PM
Xeris Pharmaceuticals: Q1 Earnings InsightsXeris Pharmaceuticals: Q1 Earnings Insights
www.benzinga.com - May 7 at 12:09 PM
Xeris Shares March Higher, Can It Continue?Xeris' Shares March Higher, Can It Continue?
www.nasdaq.com - May 7 at 12:09 PM
Xeris' Shares March Higher, Can It Continue?Xeris' Shares March Higher, Can It Continue?
finance.yahoo.com - May 7 at 12:09 PM
Xeris Pharmaceuticals Inc (XERS) Reports Q1 Loss, Lags Revenue EstimatesXeris Pharmaceuticals Inc (XERS) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 7 at 12:09 PM
This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.